ClearPoint Neuro, Inc. (CLPT)
USD 15.08
(-7.71%)
USD 15.08
(-7.71%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 21.48 Million USD | 15.51% |
| 2022 | 18.6 Million USD | 10.77% |
| 2021 | 16.79 Million USD | -38.4% |
| 2020 | 27.26 Million USD | 271.44% |
| 2019 | 7.33 Million USD | 15.66% |
| 2018 | 6.34 Million USD | -21.35% |
| 2017 | 8.06 Million USD | -1.08% |
| 2016 | 8.15 Million USD | -32.5% |
| 2015 | 12.08 Million USD | -10.4% |
| 2014 | 13.48 Million USD | -8.3% |
| 2013 | 14.7 Million USD | 30.28% |
| 2012 | 11.28 Million USD | -54.62% |
| 2011 | 24.87 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 20.44 Million USD | 7.29% |
| 2024 Q1 | 19.05 Million USD | -11.33% |
| 2023 Q4 | 21.48 Million USD | 8.84% |
| 2023 Q3 | 19.74 Million USD | -2.41% |
| 2023 FY | 21.48 Million USD | 15.51% |
| 2023 Q2 | 20.23 Million USD | 14.51% |
| 2023 Q1 | 17.66 Million USD | -5.03% |
| 2022 Q3 | 17.86 Million USD | 2.53% |
| 2022 Q4 | 18.6 Million USD | 4.16% |
| 2022 FY | 18.6 Million USD | 10.77% |
| 2022 Q1 | 16.03 Million USD | -4.5% |
| 2022 Q2 | 17.42 Million USD | 8.62% |
| 2021 Q3 | 24.58 Million USD | 0.91% |
| 2021 Q4 | 16.79 Million USD | -31.68% |
| 2021 Q1 | 30.28 Million USD | 11.07% |
| 2021 Q2 | 24.36 Million USD | -19.55% |
| 2021 FY | 16.79 Million USD | -38.4% |
| 2020 Q1 | 20.82 Million USD | 183.74% |
| 2020 Q2 | 21.69 Million USD | 4.17% |
| 2020 Q3 | 21.69 Million USD | 0.02% |
| 2020 Q4 | 27.26 Million USD | 25.65% |
| 2020 FY | 27.26 Million USD | 271.44% |
| 2019 FY | 7.33 Million USD | 15.66% |
| 2019 Q1 | 7.18 Million USD | 13.19% |
| 2019 Q3 | 7.38 Million USD | 16.01% |
| 2019 Q2 | 6.36 Million USD | -11.42% |
| 2019 Q4 | 7.33 Million USD | -0.56% |
| 2018 Q2 | 8.02 Million USD | 5.66% |
| 2018 FY | 6.34 Million USD | -21.35% |
| 2018 Q4 | 6.34 Million USD | 2.59% |
| 2018 Q3 | 6.18 Million USD | -22.96% |
| 2018 Q1 | 7.59 Million USD | -5.82% |
| 2017 Q4 | 8.06 Million USD | -1.35% |
| 2017 Q1 | 8.39 Million USD | 2.93% |
| 2017 Q3 | 8.17 Million USD | -1.73% |
| 2017 Q2 | 8.32 Million USD | -0.86% |
| 2017 FY | 8.06 Million USD | -1.08% |
| 2016 Q2 | 10.4 Million USD | -12.58% |
| 2016 Q4 | 8.15 Million USD | -3.35% |
| 2016 FY | 8.15 Million USD | -32.5% |
| 2016 Q1 | 11.9 Million USD | -1.48% |
| 2016 Q3 | 8.43 Million USD | -18.91% |
| 2015 Q2 | 13.73 Million USD | -4.43% |
| 2015 Q3 | 12.09 Million USD | -11.96% |
| 2015 FY | 12.08 Million USD | -10.4% |
| 2015 Q4 | 12.08 Million USD | -0.1% |
| 2015 Q1 | 14.37 Million USD | 6.59% |
| 2014 FY | 13.48 Million USD | -8.3% |
| 2014 Q1 | 13.18 Million USD | -10.35% |
| 2014 Q2 | 12.98 Million USD | -1.52% |
| 2014 Q3 | 14.43 Million USD | 11.14% |
| 2014 Q4 | 13.48 Million USD | -6.56% |
| 2013 Q3 | 15.13 Million USD | 9.6% |
| 2013 Q2 | 13.8 Million USD | -7.06% |
| 2013 Q1 | 14.85 Million USD | 31.59% |
| 2013 FY | 14.7 Million USD | 30.28% |
| 2013 Q4 | 14.7 Million USD | -2.81% |
| 2012 Q3 | 13.27 Million USD | -14.75% |
| 2012 Q4 | 11.28 Million USD | -14.93% |
| 2012 Q2 | 15.56 Million USD | -7.2% |
| 2012 Q1 | 16.77 Million USD | -32.56% |
| 2012 FY | 11.28 Million USD | -54.62% |
| 2011 FY | 24.87 Million USD | 0.0% |
| 2011 Q4 | 24.87 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Acutus Medical, Inc. | 54.83 Million USD | 60.816% |
| Axonics, Inc. | 82.35 Million USD | 73.909% |
| INVO Bioscience, Inc. | 19.99 Million USD | -7.467% |
| CVRx, Inc. | 39.28 Million USD | 45.298% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 90.366% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -575.311% |
| MaxCyte, Inc. | 36.1 Million USD | 40.488% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 82.666% |
| Sintx Technologies, Inc. | 6.59 Million USD | -225.921% |
| Accelerate Diagnostics, Inc. | 51.25 Million USD | 58.075% |
| Apyx Medical Corporation | 52.31 Million USD | 58.928% |
| Cutera, Inc. | 518.12 Million USD | 95.853% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -302.246% |
| NeuroPace, Inc. | 86.99 Million USD | 75.3% |
| IRIDEX Corporation | 24.91 Million USD | 13.751% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 75.525% |
| enVVeno Medical Corporation | 2.43 Million USD | -782.464% |
| TELA Bio, Inc. | 59.16 Million USD | 63.682% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 96.637% |
| UFP Technologies, Inc. | 118.04 Million USD | 81.797% |
| Modular Medical, Inc. | 2.27 Million USD | -845.775% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | 26.732% |
| LENSAR, Inc. | 22.4 Million USD | 4.11% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 99.021% |
| Surmodics, Inc. | 65.82 Million USD | 67.355% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -108.237% |
| Inogen, Inc. | 121.38 Million USD | 82.297% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -1183.632% |
| RxSight, Inc. | 22.18 Million USD | 3.155% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -4952.659% |
| Lucid Diagnostics Inc. | 29.58 Million USD | 27.359% |
| Nano-X Imaging Ltd. | 23.13 Million USD | 7.115% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -4952.659% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -784.535% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 79.458% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 96.946% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | 15.611% |
| Dynatronics Corporation | 11.78 Million USD | -82.409% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | 58.407% |
| InMode Ltd. | 75.91 Million USD | 71.694% |
| Bruker Corporation | 2.83 Billion USD | 99.242% |
| Movano Inc. | 5.97 Million USD | -259.812% |
| Orthofix Medical Inc. | 326.58 Million USD | 93.42% |
| FONAR Corporation | 57.45 Million USD | 62.602% |
| BioSig Technologies, Inc. | 4.68 Million USD | -358.655% |
| Envoy Medical, Inc. | 9.4 Million USD | -128.547% |
| Align Technology, Inc. | 2.45 Billion USD | 99.124% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 63.185% |
| Talis Biomedical Corporation | 29.22 Million USD | 26.471% |
| Cerus Corporation | 144.3 Million USD | 85.109% |
| 908 Devices Inc. | 37.49 Million USD | 42.683% |
| Nemaura Medical Inc. | 26.37 Million USD | 18.536% |
| Outset Medical, Inc. | 190.91 Million USD | 88.745% |
| NanoVibronix, Inc. | 2.68 Million USD | -700.0% |
| Venus Concept Inc. | 107.1 Million USD | 79.937% |
| Telesis Bio, Inc. | 40.87 Million USD | 47.427% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 81.146% |
| Quipt Home Medical Corp. | 136.29 Million USD | 84.234% |
| IRadimed Corporation | 20.73 Million USD | -3.627% |
| Tenon Medical, Inc. | 5.56 Million USD | -285.989% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -501.568% |
| Pulmonx Corporation | 60.63 Million USD | 64.562% |
| iCAD, Inc. | 8 Million USD | -168.566% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | -69.324% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -1062.827% |
| Viemed Healthcare, Inc. | 40.79 Million USD | 47.321% |
| SI-BONE, Inc. | 61.05 Million USD | 64.803% |
| Semler Scientific, Inc. | 6.27 Million USD | -242.711% |
| Biotricity, Inc. | 35.91 Million USD | 40.177% |
| Cytosorbents Corporation | 29.98 Million USD | 28.339% |
| DexCom, Inc. | 4.19 Billion USD | 99.488% |
| ZimVie Inc. | 795.85 Million USD | 97.3% |
| Aethlon Medical, Inc. | 2.47 Million USD | -766.574% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -79.694% |
| IceCure Medical Ltd | 4.24 Million USD | -405.957% |
| PAVmed Inc | 57.13 Million USD | 62.392% |
| Sight Sciences, Inc. | 46.43 Million USD | 53.726% |
| Insulet Corporation | 1.85 Billion USD | 98.842% |
| Profound Medical Corp. | 12.66 Million USD | -69.653% |
| electroCore, Inc. | 8.94 Million USD | -140.224% |
| Bioventus Inc. | 589.79 Million USD | 96.357% |
| InspireMD, Inc. | 8.14 Million USD | -163.916% |
| PAVmed Inc. | 57.13 Million USD | 62.392% |
| Nuwellis, Inc. | 6.78 Million USD | -216.932% |
| OrthoPediatrics Corp. | 72.56 Million USD | 70.386% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | -79.694% |
| BrainsWay Ltd. | 15.31 Million USD | -40.316% |
| BIOLASE, Inc. | 35.34 Million USD | 39.21% |
| Beyond Air, Inc. | 29.77 Million USD | 27.832% |
| AxoGen, Inc. | 101.16 Million USD | 78.759% |
| Inari Medical, Inc. | 209.32 Million USD | 89.735% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -883.067% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -1107.87% |
| AdaptHealth Corp. | 3.15 Billion USD | 99.319% |
| Quanterix Corporation | 78.08 Million USD | 72.481% |
| Viveve Medical, Inc. | 10.84 Million USD | -98.101% |
| LivaNova PLC | 1.15 Billion USD | 98.135% |
| Co-Diagnostics, Inc. | 17.63 Million USD | -21.855% |
| Varex Imaging Corporation | 668.6 Million USD | 96.786% |
| Vivani Medical, Inc. | 25.03 Million USD | 14.172% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -428.74% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -501.568% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -339.877% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 97.943% |
| TransMedics Group, Inc. | 568.84 Million USD | 96.223% |
| ReWalk Robotics Ltd. | 16.68 Million USD | -28.809% |
| NeuroMetrix, Inc. | 1.33 Million USD | -1511.853% |
| Spectral AI, Inc. | 12.4 Million USD | -73.276% |
| Hyperfine, Inc. | 9.8 Million USD | -119.265% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 91.413% |
| Biomerica, Inc. | 2.66 Million USD | -706.91% |
| Bone Biologics Corporation | 831.4 Thousand USD | -2484.55% |
| AVITA Medical, Inc. | 19.86 Million USD | -8.168% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -988.726% |
| Silk Road Medical, Inc | 114.15 Million USD | 81.177% |